Seattle’s Targeted Genetics names new CEO and president
Seattle biotechnology company Targeted Genetics has announced that H. Stewart Parker—its CEO and President—and Dr. Barrie J. Carter, PhD—its Chief Scientific Officer and Executive Vice President—have resigned.
Parker has served as Targeted Genetics’ president and CEO since 1989.
Carter served as executive vice president since 1992 and CSO since 2001.
Parker will be replaced by B.G. Susan Robinson. Robinson had been the company’s Vice President of Business Development.
Parker will remain on the company’s board of directors.
To learn more:
- Read the article by Ángel González in the Seattle Times.
- Read the company’s press release on the leadership changes.
Category: Biotechnology, Immune System
Subscribe
If you enjoyed this article, subscribe to receive more just like it.
LocalHealthGuide is a health news and information web service for Seattle and the Puget Sound Region. We are independent and unaffiliated with any hospital, medical association or insurer. If you have questions or if your group has an upcoming event that you would like us to cover, please let us know by going to our "
Add to Google
